INVOLVING THE GENERAL-PRACTITIONER IN SCREENING FOR CERVICAL-CANCER

被引:5
作者
BOON, ME
BECK, S
WIJSMANGROOTENDORST, A
机构
[1] Leiden Cytology and Pathology Laboratory, Leiden
关键词
CERVICAL CANCER; FAMILY PRACTICE; SCREENING; SMEARS;
D O I
10.1111/j.1365-2303.1994.tb00529.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In the Leiden region, the cervical cancer screening programme for the age group 35-54 years shifted in 1989 from one in which the smears were taken by specially trained paramedical personnel in health centres to a programme where the general practitioner is the smear taker. Hence, it is possible to compare the results of the two types of screening to evaluate whether involvement of general practitioners leads to better uptake of screening. In the 6 year period evaluated in this paper, the 3-yearly cytological rate per thousand for severe dysplasia or worse increased from 1.00 to 3.40; when stratified by age the positive rates were significantly higher. The histological rate per thousand for severe dysplasia increased from 0.60 to 2.09, and for carcinoma in situ from 0.35 to 1.36. All six invasive carcinomata were detected in the GP programme (0.31%). The general practitioner is clearly more able to attract the 'high-risk' groups.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 16 条
[1]  
Boon M E, 1990, Cytopathology, V1, P201, DOI 10.1111/j.1365-2303.1990.tb00348.x
[2]  
BOON ME, 1987, CANCER-AM CANCER SOC, V59, P862, DOI 10.1002/1097-0142(19870215)59:4<862::AID-CNCR2820590434>3.0.CO
[3]  
2-P
[4]   INVESTIGATION OF POSSIBLE CHANGES IN THE DETECTION OF CERVICAL-CARCINOMA IN PATIENTS OF DUTCH GENERAL-PRACTITIONERS [J].
BOON, ME ;
RIETVELD, WJ ;
KIRK, RS .
TUMORI, 1982, 68 (04) :299-305
[5]   IMPROVING CERVICAL SCREENING BY INVOLVING GENERAL-PRACTITIONERS [J].
BOON, ME ;
BECK, S .
LANCET, 1991, 338 (8768) :699-699
[6]  
BOON ME, 1993, PAP SMEAR
[7]   MODEL-BUILDING ON THE BASIS OF DUTCH CERVICAL-CANCER SCREENING DATA [J].
HABBEMA, JDF ;
VANOORTMARSSEN, GJ ;
LUBBE, JTN ;
van der Maas, PJ .
MATURITAS, 1985, 7 (01) :11-20
[8]  
HAVELOCK GM, 1990, CYTOPATHOLOGY, V1, P59
[9]  
KIRK RS, 1981, ACTA CYTOL, V25, P259
[10]   PREVENTIVE PAP-SMEARS - BALANCING COSTS, RISKS AND BENEFITS [J].
VANBALLEGOOIJEN, M ;
HABBEMA, JDF ;
VANOORTMARSSEN, GJ ;
KOOPMANSCHAP, MA ;
LUBBE, JTN ;
VANAGT, HME .
BRITISH JOURNAL OF CANCER, 1992, 65 (06) :930-933